The North America Gene Synthesis Market would witness market growth of 17.7% CAGR during the forecast period (2021-2027).
Gene synthesis is a technique that is included in synthetic biology which is being utilized with the purpose of developing artificial genes while incorporating with laboratory standards. It is widely being used for the production of fusion proteins, cloning molecules, or with the purpose to attain higher protein expression.
The number of people that are adopting gene therapy has increased the number of equipment that are required to perform gene therapy. Also, the treatment of infectious diseases requires advanced and special gene therapy equipment to offer impeccable and flawless gene sequences in a reduced time period to offer absolutely enhanced therapy outcomes which would improve the development of gene synthesis therapy further.
According to the National Institute of Health (NIH) of the United States, synthetic biology is considered as a method for the faster development of various vaccines and to cure distinct genetic disorders. Hence, these factors are anticipated to fuel the growth of the gene synthesis market in the region during the forecasting period.
The US market dominated the North America Gene Synthesis Market by Country 2020, and would continue to be a dominant market till 2027; thereby, achieving a market value of $1,515.1 million by 2027. The Canada market is expected to witness a CAGR of 20.4% during (2021 - 2027). Additionally, The Mexico market would experience a CAGR of 19.4% during (2021 - 2027).
Based on Method, the market is segmented into Solid-phase Synthesis, Chip-based Synthesis and PCR-based Enzyme Synthesis. Based on Service Type, the market is segmented into Antibody DNA Synthesis, Viral DNA Synthesis and Others. Based on Application, the market is segmented into Gene & Cell Therapy Development, Vaccine Development, Disease Diagnosis and Others. Based on End User, the market is segmented into Academic & Government Research Institutes, Biotechnology & Pharmaceutical Companies and Contract Research Organizations. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
Free Valuable Insights: The Global Gene Synthesis Market is Estimated to reach $5.2 Billion by 2027, at a CAGR of 17.9%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Genscript Biotech Corporation, Thermo Fisher Scientific, Inc., Brooks Automation, Inc., Boster Biological Technology, Twist Bioscience Corporation, Danaher Corporation, Biomatik Corporation, ProteoGenix, ProMab Biotechnologies, Inc., and OriGene Technologies, Inc.
By Method
By Service Type
By Application
By End User
By Country
Unique Offerings Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
